ID   HSP7C_RAT               Reviewed;         646 AA.
AC   P63018; P08109; P12225; Q4FZY7; Q62373; Q62374; Q62375;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1988, sequence version 1.
DT   02-OCT-2024, entry version 175.
DE   RecName: Full=Heat shock cognate 71 kDa protein {ECO:0000305};
DE            EC=3.6.4.10 {ECO:0000250|UniProtKB:P11142};
DE   AltName: Full=Heat shock 70 kDa protein 8;
GN   Name=Hspa8 {ECO:0000312|RGD:621725};
GN   Synonyms=Hsc70 {ECO:0000303|PubMed:10373374},
GN   Hsc73 {ECO:0000303|PubMed:3595567};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3595567; DOI=10.1002/j.1460-2075.1987.tb04850.x;
RA   Sorger P.K., Pelham H.R.B.;
RT   "Cloning and expression of a gene encoding hsc73, the major hsp70-like
RT   protein in unstressed rat cells.";
RL   EMBO J. 6:993-998(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3939319; DOI=10.1128/mcb.5.12.3476-3483.1985;
RA   O'Malley K., Mauron A., Barchas J.D., Kedes L.;
RT   "Constitutively expressed rat mRNA encoding a 70-kilodalton heat-shock-like
RT   protein.";
RL   Mol. Cell. Biol. 5:3476-3483(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart, and Pituitary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 4-36; 57-71; 77-108; 127-155; 160-171; 237-246;
RP   300-319; 349-357; 424-447; 452-458; 518-526; 540-550; 584-597 AND 602-609,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, Hippocampus, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [5]
RP   INTERACTION WITH DNAJC7.
RX   PubMed=10567422; DOI=10.1074/jbc.274.48.34425;
RA   Liu F.H., Wu S.J., Hu S.M., Hsiao C.D., Wang C.;
RT   "Specific interaction of the 70-kDa heat shock cognate protein with the
RT   tetratricopeptide repeats.";
RL   J. Biol. Chem. 274:34425-34432(1999).
RN   [6]
RP   INTERACTION WITH SGTA.
RX   PubMed=15708368; DOI=10.1016/j.abb.2004.12.020;
RA   Liou S.T., Wang C.;
RT   "Small glutamine-rich tetratricopeptide repeat-containing protein is
RT   composed of three structural units with distinct functions.";
RL   Arch. Biochem. Biophys. 435:253-263(2005).
RN   [7]
RP   STRUCTURE BY NMR OF 385-543.
RX   PubMed=10373374; DOI=10.1006/jmbi.1999.2776;
RA   Morshauser R.C., Hu W., Wang H., Pang Y., Flynn G.C., Zuiderweg E.R.P.;
RT   "High-resolution solution structure of the 18 kDa substrate-binding domain
RT   of the mammalian chaperone protein Hsc70.";
RL   J. Mol. Biol. 289:1387-1403(1999).
CC   -!- FUNCTION: Molecular chaperone implicated in a wide variety of cellular
CC       processes, including protection of the proteome from stress, folding
CC       and transport of newly synthesized polypeptides, chaperone-mediated
CC       autophagy, activation of proteolysis of misfolded proteins, formation
CC       and dissociation of protein complexes, and antigen presentation. Plays
CC       a pivotal role in the protein quality control system, ensuring the
CC       correct folding of proteins, the re-folding of misfolded proteins and
CC       controlling the targeting of proteins for subsequent degradation. This
CC       is achieved through cycles of ATP binding, ATP hydrolysis and ADP
CC       release, mediated by co-chaperones. The co-chaperones have been shown
CC       to not only regulate different steps of the ATPase cycle of HSP70, but
CC       they also have an individual specificity such that one co-chaperone may
CC       promote folding of a substrate while another may promote degradation.
CC       The affinity of HSP70 for polypeptides is regulated by its nucleotide
CC       bound state. In the ATP-bound form, it has a low affinity for substrate
CC       proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a
CC       conformational change that increases its affinity for substrate
CC       proteins. HSP70 goes through repeated cycles of ATP hydrolysis and
CC       nucleotide exchange, which permits cycles of substrate binding and
CC       release. The HSP70-associated co-chaperones are of three types: J-
CC       domain co-chaperones HSP40s (stimulate ATPase hydrolysis by HSP70), the
CC       nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate
CC       conversion of HSP70 from the ADP-bound to the ATP-bound state thereby
CC       promoting substrate release), and the TPR domain chaperones such as
CC       HOPX and STUB1. Plays a critical role in mitochondrial import, delivers
CC       preproteins to the mitochondrial import receptor TOMM70. Acts as a
CC       repressor of transcriptional activation. Inhibits the transcriptional
CC       coactivator activity of CITED1 on Smad-mediated transcription.
CC       Component of the PRP19-CDC5L complex that forms an integral part of the
CC       spliceosome and is required for activating pre-mRNA splicing. May have
CC       a scaffolding role in the spliceosome assembly as it contacts all other
CC       components of the core complex. Binds bacterial lipopolysaccharide
CC       (LPS) and mediates LPS-induced inflammatory response, including TNF
CC       secretion by monocytes. Substrate recognition component in chaperone-
CC       mediated autophagy (CMA), a selective protein degradation process that
CC       mediates degradation of proteins with a -KFERQ motif: HSPA8/HSC70
CC       specifically recognizes and binds cytosolic proteins bearing a -KFERQ
CC       motif and promotes their recruitment to the surface of the lysosome
CC       where they bind to lysosomal protein LAMP2. KFERQ motif-containing
CC       proteins are eventually transported into the lysosomal lumen where they
CC       are degraded. In conjunction with LAMP2, facilitates MHC class II
CC       presentation of cytoplasmic antigens by guiding antigens to the
CC       lysosomal membrane for interaction with LAMP2 which then elicits MHC
CC       class II presentation of peptides to the cell membrane. Participates in
CC       the ER-associated degradation (ERAD) quality control pathway in
CC       conjunction with J domain-containing co-chaperones and the E3 ligase
CC       STUB1. It is recruited to clathrin-coated vesicles through its
CC       interaction with DNAJC6 leading to activation of HSPA8/HSC70 ATPase
CC       activity and therefore uncoating of clathrin-coated vesicles (By
CC       similarity). {ECO:0000250|UniProtKB:P11142,
CC       ECO:0000250|UniProtKB:P19120}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.10;
CC         Evidence={ECO:0000250|UniProtKB:P11142};
CC   -!- SUBUNIT: Identified in a IGF2BP1-dependent mRNP granule complex
CC       containing untranslated mRNAs (By similarity). Interacts with PACRG (By
CC       similarity). Interacts with HSPH1/HSP105 (By similarity). Interacts
CC       with IRAK1BP1 and BAG1 (By similarity). Interacts with DNAJC7
CC       (PubMed:10567422). Interacts with DNAJB12 (via J domain) (By
CC       similarity). Interacts with DNAJB14 (via J domain) (By similarity).
CC       Interacts (via C-terminus) with the E3 ligase STUB1 forming a 210 kDa
CC       complex of one STUB1 and two HSPA8 molecules (By similarity). Interacts
CC       with CITED1 (via N-terminus); the interaction suppresses the
CC       association of CITED1 to p300/CBP and Smad-mediated transcription
CC       transactivation (By similarity). Component of the PRP19-CDC5L splicing
CC       complex composed of a core complex comprising a homotetramer of PRPF19,
CC       CDC5L, PLRG1 and BCAS2, and at least three less stably associated
CC       proteins CTNNBL1, CWC15 and HSPA8 (By similarity). Interacts with TRIM5
CC       (By similarity). Part of a complex composed at least of ASH2L, EMSY,
CC       HCFC1, HSPA8, CCAR2, MATR3, MKI67, RBBP5, TUBB2A, WDR5 and ZNF335; this
CC       complex may have a histone H3-specific methyltransferase activity (By
CC       similarity). Interacts with METTL21A (By similarity). Following LPS
CC       binding, may form a complex with CXCR4, GDF5 and HSP90AA1 (By
CC       similarity). Interacts with PRKN (By similarity). Interacts with FOXP3
CC       (By similarity). Interacts with DNAJC9 (via J domain) (By similarity).
CC       Interacts with MLLT11 (By similarity). Interacts with RNF207 (By
CC       similarity). Interacts with DNAJC21 (By similarity). Interacts with
CC       DNAJB2 (By similarity). Interacts with TTC1 (via TPR repeats) (By
CC       similarity). Interacts with SGTA (via TPR repeats) (PubMed:15708368).
CC       Interacts with HSF1 (via transactivation domain) (By similarity).
CC       Interacts with HOPX, STUB1, HSP40, HSP90, BAG2 and BAG3 (By
CC       similarity). Interacts with DNAJC12 (By similarity). Interacts with
CC       HSPC138 (By similarity). Interacts with ZMYND10 (By similarity).
CC       Interacts with VGF-derived peptide TLQP-21 (By similarity). Interacts
CC       with BCL2L1, GIMAP5 and MCL1; the interaction with BCL2L1 or MCL1 is
CC       impaired in the absence of GIMAP5 (By similarity). Interacts with
CC       NLPR12 (By similarity). Interacts with TTC4 (By similarity). Interacts
CC       with TOMM70; the interaction is required for preprotein mitochondrial
CC       import (By similarity). May interact with DNJC9; the interaction seems
CC       to be histone-dependent (By similarity). Interacts with BAG5 and JPH2;
CC       the interaction with JPH2 is increased in the presence of BAG5 (By
CC       similarity). Interacts with DNAJC6 (via J domain) in an ATP-dependent
CC       manner; this interaction stimulates the HSPA8's ATPase activity. Forms
CC       a complex composed of HSPA8, CLTC and DNAJC6 (By similarity). Interacts
CC       with HSPA8; this interaction modulates migratory and antigen-presenting
CC       capacities of dendritic cells (By similarity).
CC       {ECO:0000250|UniProtKB:P11142, ECO:0000250|UniProtKB:P19120,
CC       ECO:0000250|UniProtKB:P63017, ECO:0000269|PubMed:10567422,
CC       ECO:0000269|PubMed:15708368}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P11142}.
CC       Melanosome {ECO:0000250|UniProtKB:P11142}. Nucleus, nucleolus
CC       {ECO:0000250|UniProtKB:P11142}. Cell membrane
CC       {ECO:0000250|UniProtKB:P11142}. Lysosome membrane
CC       {ECO:0000250|UniProtKB:P11142}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:P11142}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:P11142}. Note=Localized in cytoplasmic mRNP
CC       granules containing untranslated mRNAs. Translocates rapidly from the
CC       cytoplasm to the nuclei, and especially to the nucleoli, upon heat
CC       shock. {ECO:0000250|UniProtKB:P11142}.
CC   -!- INDUCTION: Constitutively synthesized.
CC   -!- DOMAIN: The N-terminal nucleotide binding domain (NBD) (also known as
CC       the ATPase domain) is responsible for binding and hydrolyzing ATP. The
CC       C-terminal substrate-binding domain (SBD) (also known as peptide-
CC       binding domain) binds to the client/substrate proteins. The two domains
CC       are allosterically coupled so that, when ATP is bound to the NBD, the
CC       SBD binds relatively weakly to clients. When ADP is bound in the NBD, a
CC       conformational change enhances the affinity of the SBD for client
CC       proteins. {ECO:0000250|UniProtKB:P11142}.
CC   -!- PTM: Acetylated. {ECO:0000250|UniProtKB:P11142}.
CC   -!- PTM: ISGylated. {ECO:0000250|UniProtKB:P11142}.
CC   -!- PTM: Trimethylation at Lys-561 reduces fibrillar SNCA binding.
CC       {ECO:0000250|UniProtKB:P11142}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y00054; CAA68265.1; -; Genomic_DNA.
DR   EMBL; M11942; AAA41354.1; -; mRNA.
DR   EMBL; BC061547; AAH61547.1; -; mRNA.
DR   EMBL; BC098914; AAH98914.1; -; mRNA.
DR   PIR; S07197; S07197.
DR   RefSeq; NP_077327.1; NM_024351.2.
DR   PDB; 1CKR; NMR; -; A=385-543.
DR   PDB; 1UD0; X-ray; 3.45 A; A/B/C/D=542-646.
DR   PDB; 2V7Z; X-ray; 3.50 A; A/B=1-543.
DR   PDB; 7HSC; NMR; -; A=385-543.
DR   PDBsum; 1CKR; -.
DR   PDBsum; 1UD0; -.
DR   PDBsum; 2V7Z; -.
DR   PDBsum; 7HSC; -.
DR   AlphaFoldDB; P63018; -.
DR   SMR; P63018; -.
DR   BioGRID; 246629; 25.
DR   CORUM; P63018; -.
DR   DIP; DIP-33262N; -.
DR   IntAct; P63018; 15.
DR   MINT; P63018; -.
DR   STRING; 10116.ENSRNOP00000058593; -.
DR   GlyGen; P63018; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P63018; -.
DR   PhosphoSitePlus; P63018; -.
DR   SwissPalm; P63018; -.
DR   jPOST; P63018; -.
DR   PaxDb; 10116-ENSRNOP00000058593; -.
DR   Ensembl; ENSRNOT00000044608.6; ENSRNOP00000042159.6; ENSRNOG00000034066.6.
DR   Ensembl; ENSRNOT00055032010; ENSRNOP00055025891; ENSRNOG00055018769.
DR   Ensembl; ENSRNOT00060027805; ENSRNOP00060022339; ENSRNOG00060016236.
DR   Ensembl; ENSRNOT00060042781; ENSRNOP00060035439; ENSRNOG00060024746.
DR   Ensembl; ENSRNOT00065047766; ENSRNOP00065039178; ENSRNOG00065027723.
DR   GeneID; 24468; -.
DR   KEGG; rno:24468; -.
DR   UCSC; RGD:621725; rat.
DR   AGR; RGD:621725; -.
DR   CTD; 3312; -.
DR   RGD; 621725; Hspa8.
DR   eggNOG; KOG0101; Eukaryota.
DR   GeneTree; ENSGT00950000183206; -.
DR   InParanoid; P63018; -.
DR   OMA; KANPIMM; -.
DR   OrthoDB; 143at2759; -.
DR   PhylomeDB; P63018; -.
DR   Reactome; R-RNO-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-RNO-3371497; HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand.
DR   Reactome; R-RNO-3371568; Attenuation phase.
DR   Reactome; R-RNO-3371571; HSF1-dependent transactivation.
DR   Reactome; R-RNO-432720; Lysosome Vesicle Biogenesis.
DR   Reactome; R-RNO-432722; Golgi Associated Vesicle Biogenesis.
DR   Reactome; R-RNO-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   Reactome; R-RNO-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8876725; Protein methylation.
DR   Reactome; R-RNO-888590; GABA synthesis, release, reuptake and degradation.
DR   Reactome; R-RNO-9833482; PKR-mediated signaling.
DR   EvolutionaryTrace; P63018; -.
DR   PRO; PR:P63018; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   GO; GO:0032279; C:asymmetric synapse; IDA:RGD.
DR   GO; GO:0005776; C:autophagosome; IDA:RGD.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0043198; C:dendritic shaft; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0070062; C:extracellular exosome; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0098690; C:glycinergic synapse; IDA:SynGO.
DR   GO; GO:0005882; C:intermediate filament; IDA:RGD.
DR   GO; GO:0005770; C:late endosome; ISO:RGD.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:1990836; C:lysosomal matrix; IDA:MGI.
DR   GO; GO:0005765; C:lysosomal membrane; IDA:MGI.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005874; C:microtubule; IDA:RGD.
DR   GO; GO:0044309; C:neuron spine; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0001917; C:photoreceptor inner segment; IDA:RGD.
DR   GO; GO:0098684; C:photoreceptor ribbon synapse; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0099524; C:postsynaptic cytosol; IDA:SynGO.
DR   GO; GO:0014069; C:postsynaptic density; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; ISO:RGD.
DR   GO; GO:0098793; C:presynapse; IDA:SynGO.
DR   GO; GO:0099523; C:presynaptic cytosol; IDA:SynGO.
DR   GO; GO:0101031; C:protein folding chaperone complex; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0000974; C:Prp19 complex; ISS:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISS:UniProtKB.
DR   GO; GO:0005681; C:spliceosomal complex; ISO:RGD.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:RGD.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0031686; F:A1 adenosine receptor binding; IPI:RGD.
DR   GO; GO:0043531; F:ADP binding; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IDA:MGI.
DR   GO; GO:0140545; F:ATP-dependent protein disaggregase activity; ISO:RGD.
DR   GO; GO:0140662; F:ATP-dependent protein folding chaperone; IEA:InterPro.
DR   GO; GO:0055131; F:C3HC4-type RING finger domain binding; ISO:RGD.
DR   GO; GO:1990833; F:clathrin-uncoating ATPase activity; IDA:RGD.
DR   GO; GO:0019899; F:enzyme binding; IPI:RGD.
DR   GO; GO:0001664; F:G protein-coupled receptor binding; ISO:RGD.
DR   GO; GO:0031072; F:heat shock protein binding; ISO:RGD.
DR   GO; GO:0042277; F:peptide binding; IDA:RGD.
DR   GO; GO:0001786; F:phosphatidylserine binding; ISO:RGD.
DR   GO; GO:1904593; F:prostaglandin binding; IPI:RGD.
DR   GO; GO:0044183; F:protein folding chaperone; IBA:GO_Central.
DR   GO; GO:0051087; F:protein-folding chaperone binding; ISO:RGD.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; ISS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0051082; F:unfolded protein binding; IMP:RGD.
DR   GO; GO:0046034; P:ATP metabolic process; ISO:RGD.
DR   GO; GO:0008088; P:axo-dendritic transport; IEP:RGD.
DR   GO; GO:0071276; P:cellular response to cadmium ion; IEP:RGD.
DR   GO; GO:0034605; P:cellular response to heat; IEP:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0021549; P:cerebellum development; IEP:RGD.
DR   GO; GO:0051085; P:chaperone cofactor-dependent protein refolding; ISO:RGD.
DR   GO; GO:0061684; P:chaperone-mediated autophagy; IDA:ParkinsonsUK-UCL.
DR   GO; GO:1904764; P:chaperone-mediated autophagy translocation complex disassembly; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0061077; P:chaperone-mediated protein folding; IDA:RGD.
DR   GO; GO:0072318; P:clathrin coat disassembly; IDA:UniProtKB.
DR   GO; GO:0044849; P:estrous cycle; IEP:RGD.
DR   GO; GO:0030900; P:forebrain development; IEP:RGD.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; IEP:RGD.
DR   GO; GO:0001822; P:kidney development; IEP:RGD.
DR   GO; GO:0061738; P:late endosomal microautophagy; ISO:RGD.
DR   GO; GO:0098880; P:maintenance of postsynaptic specialization structure; IDA:SynGO.
DR   GO; GO:0044788; P:modulation by host of viral process; ISO:RGD.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IMP:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:1900226; P:negative regulation of NLRP3 inflammasome complex assembly; ISO:RGD.
DR   GO; GO:1902904; P:negative regulation of supramolecular fiber organization; ISO:RGD.
DR   GO; GO:0044829; P:positive regulation by host of viral genome replication; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR   GO; GO:0097214; P:positive regulation of lysosomal membrane permeability; IMP:RGD.
DR   GO; GO:0048026; P:positive regulation of mRNA splicing, via spliceosome; ISO:RGD.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; IMP:RGD.
DR   GO; GO:1904592; P:positive regulation of protein refolding; IDA:RGD.
DR   GO; GO:0045862; P:positive regulation of proteolysis; IDA:RGD.
DR   GO; GO:0001916; P:positive regulation of T cell mediated cytotoxicity; IMP:RGD.
DR   GO; GO:0006457; P:protein folding; ISO:RGD.
DR   GO; GO:0006606; P:protein import into nucleus; IMP:RGD.
DR   GO; GO:0042026; P:protein refolding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0061740; P:protein targeting to lysosome involved in chaperone-mediated autophagy; ISS:UniProtKB.
DR   GO; GO:0044743; P:protein transmembrane import into intracellular organelle; IEP:RGD.
DR   GO; GO:0032984; P:protein-containing complex disassembly; IMP:MGI.
DR   GO; GO:0051726; P:regulation of cell cycle; ISO:RGD.
DR   GO; GO:0099175; P:regulation of postsynapse organization; ISO:RGD.
DR   GO; GO:0061635; P:regulation of protein complex stability; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0031647; P:regulation of protein stability; ISO:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0010045; P:response to nickel cation; IEP:RGD.
DR   GO; GO:1990834; P:response to odorant; IEP:RGD.
DR   GO; GO:0032570; P:response to progesterone; IEP:RGD.
DR   GO; GO:0042594; P:response to starvation; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEP:RGD.
DR   GO; GO:1990832; P:slow axonal transport; IEP:RGD.
DR   GO; GO:0016191; P:synaptic vesicle uncoating; IDA:SynGO.
DR   CDD; cd10233; HSPA1-2_6-8-like_NBD; 1.
DR   DisProt; DP02986; -.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 3.30.30.30; -; 1.
DR   Gene3D; 3.30.420.40; -; 2.
DR   IDEAL; IID50176; -.
DR   InterPro; IPR043129; ATPase_NBD.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   PANTHER; PTHR19375:SF379; HEAT SHOCK COGNATE 71 KDA PROTEIN; 1.
DR   PANTHER; PTHR19375; HEAT SHOCK PROTEIN 70KDA; 1.
DR   Pfam; PF00012; HSP70; 1.
DR   PRINTS; PR00301; HEATSHOCK70.
DR   SUPFAM; SSF53067; Actin-like ATPase domain; 2.
DR   SUPFAM; SSF100934; Heat shock protein 70kD (HSP70), C-terminal subdomain; 1.
DR   SUPFAM; SSF100920; Heat shock protein 70kD (HSP70), peptide-binding domain; 1.
DR   PROSITE; PS00297; HSP70_1; 1.
DR   PROSITE; PS00329; HSP70_2; 1.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Autophagy; Cell membrane;
KW   Chaperone; Cytoplasm; Direct protein sequencing; Hydrolase;
KW   Isopeptide bond; Lysosome; Membrane; Methylation; mRNA processing;
KW   mRNA splicing; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repressor; Spliceosome; Stress response; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   CHAIN           2..646
FT                   /note="Heat shock cognate 71 kDa protein"
FT                   /id="PRO_0000078273"
FT   REGION          2..386
FT                   /note="Nucleotide-binding domain (NBD)"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   REGION          186..377
FT                   /note="Interaction with BAG1"
FT                   /evidence="ECO:0000250"
FT   REGION          394..509
FT                   /note="Substrate-binding domain (SBD)"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   REGION          614..646
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         12..15
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         14
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   BINDING         15
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   BINDING         71
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         202..204
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         202
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   BINDING         268..275
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         268
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   BINDING         271
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   BINDING         275
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   BINDING         339..342
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250"
FT   BINDING         339
FT                   /ligand="ADP"
FT                   /ligand_id="ChEBI:CHEBI:456216"
FT                   /evidence="ECO:0000250|UniProtKB:P19120"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         108
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P63017"
FT   MOD_RES         153
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         246
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         319
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         319
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P63017"
FT   MOD_RES         328
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P63017"
FT   MOD_RES         329
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         362
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         469
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         512
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P63017"
FT   MOD_RES         512
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P63017"
FT   MOD_RES         524
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P63017"
FT   MOD_RES         541
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         561
FT                   /note="N6,N6,N6-trimethyllysine; by METTL21A; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         561
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         589
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         597
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   MOD_RES         601
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   CROSSLNK        512
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   CROSSLNK        512
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11142"
FT   STRAND          6..10
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   STRAND          13..22
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   STRAND          25..28
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   STRAND          32..34
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   STRAND          41..44
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   STRAND          49..52
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   HELIX           53..58
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   TURN            59..61
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   STRAND          66..68
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   TURN            71..75
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   HELIX           81..86
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   STRAND          91..97
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   STRAND          100..105
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   STRAND          112..114
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   HELIX           116..135
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   STRAND          141..146
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   HELIX           152..165
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   STRAND          168..174
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   HELIX           175..182
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   TURN            183..186
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   STRAND          193..200
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   STRAND          205..213
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   STRAND          216..223
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   HELIX           230..249
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   HELIX           257..276
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   STRAND          278..288
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   STRAND          291..298
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   HELIX           299..305
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   HELIX           307..312
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   HELIX           314..323
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   HELIX           328..330
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   STRAND          332..338
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   HELIX           339..342
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   HELIX           344..353
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   TURN            354..356
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   TURN            365..367
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   HELIX           368..380
FT                   /evidence="ECO:0007829|PDB:2V7Z"
FT   STRAND          388..391
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   STRAND          396..399
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   STRAND          401..405
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   TURN            406..408
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   STRAND          409..411
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   STRAND          418..429
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   STRAND          431..434
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   STRAND          438..445
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   STRAND          447..450
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   STRAND          452..461
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   STRAND          468..470
FT                   /evidence="ECO:0007829|PDB:7HSC"
FT   STRAND          472..481
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   TURN            482..484
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   STRAND          485..492
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   TURN            493..496
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   STRAND          497..503
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   HELIX           511..518
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   TURN            519..521
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   HELIX           522..527
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   TURN            532..534
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   STRAND          537..541
FT                   /evidence="ECO:0007829|PDB:1CKR"
FT   HELIX           542..553
FT                   /evidence="ECO:0007829|PDB:1UD0"
FT   HELIX           556..558
FT                   /evidence="ECO:0007829|PDB:1UD0"
FT   TURN            559..561
FT                   /evidence="ECO:0007829|PDB:1UD0"
FT   HELIX           564..595
FT                   /evidence="ECO:0007829|PDB:1UD0"
FT   HELIX           597..610
FT                   /evidence="ECO:0007829|PDB:1UD0"
SQ   SEQUENCE   646 AA;  70871 MW;  03A27B30E6C076ED CRC64;
     MSKGPAVGID LGTTYSCVGV FQHGKVEIIA NDQGNRTTPS YVAFTDTERL IGDAAKNQVA
     MNPTNTVFDA KRLIGRRFDD AVVQSDMKHW PFMVVNDAGR PKVQVEYKGE TKSFYPEEVS
     SMVLTKMKEI AEAYLGKTVT NAVVTVPAYF NDSQRQATKD AGTIAGLNVL RIINEPTAAA
     IAYGLDKKVG AERNVLIFDL GGGTFDVSIL TIEDGIFEVK STAGDTHLGG EDFDNRMVNH
     FIAEFKRKHK KDISENKRAV RRLRTACERA KRTLSSSTQA SIEIDSLYEG IDFYTSITRA
     RFEELNADLF RGTLDPVEKA LRDAKLDKSQ IHDIVLVGGS TRIPKIQKLL QDFFNGKELN
     KSINPDEAVA YGAAVQAAIL SGDKSENVQD LLLLDVTPLS LGIETAGGVM TVLIKRNTTI
     PTKQTQTFTT YSDNQPGVLI QVYEGERAMT KDNNLLGKFE LTGIPPAPRG VPQIEVTFDI
     DANGILNVSA VDKSTGKENK ITITNDKGRL SKEDIERMVQ EAEKYKAEDE KQRDKVSSKN
     SLESYAFNMK ATVEDEKLQG KINDEDKQKI LDKCNEIISW LDKNQTAEKE EFEHQQKELE
     KVCNPIITKL YQSAGGMPGG MPGGFPGGGA PPSGGASSGP TIEEVD
//
